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ABSTRACT
Background: Several treatments for oral papillomatosis in dogs, with satisfactory results, have already been described in 
the literature. However, there is need for further studies regarding remission time, association and exposure to drugs, side 
effects, cost-effectiveness and reproducibility of results. Autohemotherapy (AHT) is a therapeutic technique increasingly 
used in veterinary medicine that has been providing satisfactory clinical results to treat several pathologies. The procedure 
consists of removing blood by intravenous puncture that is immediately re-administered via intramuscular, subcutaneous, 
intravenous or intradermal. Although the empirical isolated use via intramuscular reached excellent results in routine medi-
cal treatment of dogs and since few studies and protocols have been described for this species, many times the treatment 
is based on the experience with the bovine papillomatosis. To this end, this report describes a case of canine oral papil-
lomatosis treated with autohemotherapy (AHT), emphasizing the dosage and clinical evolution of the case.
Case: A one-year-old mongrel dog rescued from the street eight months earlier was treated. The animal was thin resulting 
from the small food amount ingested due to feeding difficulty, infested with ticks, had bad breath and few small warts on 
the lips, which, after five months, grew and multiplied, and were distributed throughout the oral cavity. The animal clini-
cal history led to papillomatosis diagnosis, which was confirmed by cytological and histopathological exams. The AHT 
treatment consisted of taking 5 mL of whole blood without EDTA and immediately injecting this volume intramuscularly, 
every four days until the total remission of the clinical symptoms. Every four days, the papilloma fall off, and involution 
processes were recorded through a detailed macroscopic analysis of the warts (quantity, consistency, color and size), as 
well as hematological evaluations (blood count, hemoparasite screening and total plasm protein), which were performed 
before each AHT treatment until the complete clinical resolution of the disease (24 days).
Discussion: The dose adopted in this autohemotherapy study was clinically effective since the papillomas started to fall 
off after four days of therapy, with total resolution in 24 days. Therefore, it can be concluded that the 5 mL AHT injected 
intramuscularly every four days reduced treatment time and decreased therapeutic costs. There are few studies evaluating 
more accurately the hematological aspects related to the therapeutic use of autohemotherapy to treat canine oral papil-
lomatosis, the existing reports are restricted to the initial measurement as an evaluation of the general condition of the 
patient and/or diagnosis of possible basal diseases. In this study, no changes were observed in the blood count during the 
entire therapeutic process, demonstrating that the AHT did not interfere in the red series dynamics of the treated animal. 
Additionally, thrombocytosis followed by thrombocytopenia exhibited a correlation with the macroscopic appearance of 
warts [enlargement and modified color, texture, shape and consistency]. This observation is possibly related to a platelet 
mobilization toward the site of action [warts], so that there was a modulation in the immune response, amplifying the 
inflammatory process and tissue repair, which resulted in the fall off and involution of the papillomas.
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INTRODUCTION
Papillomatosis is a benign and opportunistic 
tumor, mediated by a virus of the Papillomavirus genus, 
which affects dogs, especially puppies. More often it is 
characterized by oral verrucous lesions that begin on 
the lips and, in the presence of immunosuppression, 
organic weakness or mechanical abrasion, can poten-
tially develop and spread in the oral mucosa, tongue, 
palate, pharynx and epiglottis, possibly requiring an 
immediate clinical-surgical procedure and/or therapy, 
depending on the lesion extension [1,2].
Autohemotherapy (AHT) is a widely used 
therapeutic technique in veterinary that presents satis-
factory clinical results to treat several pathologies [8]. 
The procedure consists of collecting a whole blood 
sample from the sick animal, which is administered 
immediately intramuscular, subcutaneous, intravenous 
or intradermal [8,20]. Some action mechanisms have 
already been suggested, emphasizing activation and 
subsequent potentiation of the Mononuclear Phagocytic 
System (SMF) [20] and immunomodulatory action [8].
The few studies describing the use of this 
therapy to treat oral papillomatosis in dogs are re-
stricted to intralesional application [4] or associated 
with other drugs [7]. Although its isolated empirical 
use, intramuscularly, has shown excellent results in the 
medical clinic routine of canines, it is based mostly on 
the experience with bovine papillomatosis since there 
are few works and protocols described for treating 
dogs. Thus, this case report describes the AHT to treat a 
dog with oral papillomatosis, emphasizing the dosage, 
remission of the lesions and hematological aspects.
CASE 
A one-year-old mongrel dog, weighing 3 kg, 
which was not vaccinated and had been dewormed on 
the day before surgery, was treated in the Small Animal 
Clinic of the Universidade Federal de Campina Grande, 
Campus de Patos, PB, Brazil. The animal, which had 
been rescued from the street eight months earlier, was 
infested with ticks, thin and eating only small amounts 
of food with difficulty, had bad breath and few small 
warts on the lips, which after five months multiplied 
and spread throughout the oral cavity.
Physical examination revealed discreet apathy, 
regular body score, ocular mucous and oral mucosa 
slightly pale, halitosis, multiple increases of smooth to 
verrucous volumes. The cauliflower-like warts ranged 
from 0.2 to 3.5 cm in size, were rosy colored, firm, 
located in the gingiva, oral cavity and lower and upper 
lips (Figure 1 A and C). The blood count results showed 
unchanged physiological parameters.
The history and clinical evaluation indicated 
a moderate-grade oral papillomatosis diagnosis [9]. 
Therefore, a hematological evaluation was requested 
[hemogram with hemoparasite (Hg + PHem) and total 
plasma protein (ppt), as well as cytology and biopsy of 
the warts. The cytological examination showed moder-
ate cellularity composed of squamous epithelial cells 
in all development stages, but predominantly mature 
forms, which had benign-looking nuclei (Figure 2 A 
and B). These characteristics suggested papillomatosis 
diagnosis, which was confirmed in the histopathologi-
cal evaluation [1,6].
The owner after being given an explanation on 
the therapeutic technique to be adopted authorized the 
treatment. The autohemotherapy consisted of asepti-
cally collecting a 5 mL whole blood sample without 
anticoagulant from the jugular vein, which following 
trichotomy and asepsis was immediately injected 
Figure 1. A & C- Macroscopic appearance of a dog with oral 
papillomatosis before AHT treatment; B & D- Absence of 
papillomas after 24 days of AHT treatment.
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Figure 2. A & B- Cytological aspect of a dog with oral 
papillomatosis characterized by squamous epithelial cells [Panótico 
rápido; x1000].
A B
M Nº Size (cm) Layout Texture Color Shape Consistence
M0 92 0.2-3.0 individual rough tospiculate
rosy/albescent/
enegrecido rounded/oval firm





M8 59 0.4-3.5 individual/coalescent smooth rosy to reddish rounded elastic
M12 21 0.2-0.4 individual/coalescent smooth light pink rounded elastic
M16 5 0.1-0.2 individual smooth light pink rounded elastic
M20 aus aus aus aus aus aus aus
M24 aus aus aus aus aus aus aus
M: moments; Nº: number of papillomas; aus: absent.
Chart 1. Macroscopic evaluation of the involution process of oral papillomas in a dog treated with AHT.
intramuscularly into the semitendinosus or semimem-
branosus muscles. The treatment was repeated every 
four days, totaling 24 days of therapy (six applications).
Before each application and after complet-
ing the six applications, 1.5 mL blood samples were 
collected to perform new hematological evaluations 
[Hg + PHem and ppt], totaling seven hematological 
analyses (M0, M4, M8, M12, M16, M20 and M24) 
[Table 1]. Also, the involution process of the papillo-
mas was followed by macroscopic analysis [size, color, 
texture, shape, consistency and quantity] throughout 
the treatment period. The regression process started 
immediately, with 14 papillomas falling off, after the 
first application (4 days), and total disease remission 
after six applications (24 days) [Table 1].
After the second application, the papillomas 
changed color while size increased significantly. 
However, from the third application, the warts started 
to progressively reduce, change color and shape, and 
disappeared after 20 days of treatment (Chart 1).
The results of the blood counts showed eosino-
philia in M0, a tendency to thrombocytosis (M8) at 
other time intervals compared to M0 and M4, followed 
by thrombocytopenia (M12, M16 and M20). Anemia 
was not observed throughout the evaluation process. 
No side effects were observed during the treatment, 
and there was no recurrence after one year.
DISCUSSION
Papillomatosis has been described as self-
limiting while the verrucous processes in dogs regress 
within a period of 4 to 8 weeks after the onset of the 
lesions, but may occasionally remain and multiply 
[11]. In this case, spontaneous regression of the papil-
lomas was not observed since the disease evolved and 
the warts multiplied over a period of more than five 
months, therefore, excluding the self-limiting hypoth-
esis and justifying a therapeutic intervention.
Factors such as immunological immaturity, im-
munosuppression, and organic weakness are involved 
in the manifestation and development of papillomas 
[12]. The dog of this case report was a street animal 
with no history of deworming with intense eosinophilia 
as indicated by the initial hematological examination 
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Variable
 Period of evaluation and treatment (days)
Reference Values*
M0 M4 M8 M12 M16 M20 M24
Red blood cells 7.15 6.87 7.08 6.78 6.33 8.01 5.96 5.5-8.5 milh/mm3
Hemoglobin 15 14 14 14 13 16 12 12-18 g/dL
Hematocrit 45 42 44 42 41 49 38 37-55 %
VCM 63.3 61.7 62.8 70 65 61.2 63.6 60-77.0 fl
CHCM 33.3 33.3 31.8 33.3 31.7 32.6 32.2 30-36 %
Leucocytes 13.700 11.650 14.700 15.650 9.900 11.400 7.800 6.000-17.000/mm3
Myelocytes 0 0 0 0 0 0 0 0-0/mm3
Metamyelocytes 0 0 0 0 0 0 0 0-0/mm3
Rods 0 0 0 0 0 0 0 0-510/mm3
Segmented 7.398 7.722 10.437 10.205 7.128 6.826 3.350 3.600-13.090/mm3
Lymphocytes 2.192 3.042 3.528 4.396 1.287 2.290 3.900 720-5100/mm3
Monocytes 411 234 294 314 396 684 400 180-1700/mm3
Eosinophils 3.699 702 441 785 998 1600 150 120-1700/mm3
Basophils 0 0 0 0 0 0 0 0-170/mm3
Platelets 208.000 202.000 410.000 91.000 180.000 136.000 215.000 200-500x103/mm3
ppt 6.8 7.0 7.0 7.0 6.7 7.9 7.6 5.5-8 g/dL
Hemoparasites neg neg neg neg neg neg neg negative
E. canis** nr nr nr neg neg neg neg negative
Table 1. Hematologic findings of a dog with oral papillomatosis treated with autohemotherapy intramuscularly every four days for 24 days.
[M0], thus suggesting verminosis [13] as a debilitating 
underlying organic cause as reported by Lane & Tüb-
besing [23]. Also, the dog was young and, therefore, 
immunologically immature, and the lack of vaccine 
protocol [9,12] may have also contributed to the wors-
ening and evolution of the clinical symptoms.
The macroscopic characteristics observed dur-
ing the initial clinical care agreed with the symptoms 
already described in the literature for oral papilloma-
tosis [3,4,7,15], but a detailed macroscopic description 
of the involution process such as in this study (Table 
1) has not been addressed to our knowledge [3]. Such 
characterization is necessary so that the clinician has 
a better perception and can correlate the evolution of 
the clinical symptoms with the therapeutic efficacy, 
especially when using AHT.
The diagnosis of canine papillomatosis is rou-
tinely supported by clinical-epidemiological findings 
[15]. However, due to similar macroscopic charac-
teristics, it should be differentiated from fibromatous 
epulides, transmissible venereal tumor and squamous 
cell carcinoma [16]. Therefore, to determine the thera-
peutic procedure to be adopted, other complementary 
diagnostic methods should be performed, especially the 
histopathological and immunohistochemical analyses 
[1,6]. In this report, although the histopathological 
findings confirmed the clinical suspicion, the cytologi-
cal findings allowed an early diagnosis [17], speeding 
up the beginning of the clinical-therapeutic conduct.
The dosage adopted for the AHT in this study 
was clinically effective since the papillomas started 
to fall off after four days of therapy and had total 
resolution in 24 days, evidencing the stimulating im-
munological potential of the therapy [8,18,19]. This 
finding may be better elucidated compared to other 
studies involving AHT, in which the remission onset 
was observed after seven days and total resolution be-
tween 24-30 days [4,7]. Thus, the 5 mL intramuscular 
application every four days reduced treatment time and 
decreased therapeutic costs.
Few studies evaluate more accurately the hema-
tological aspects related to the use of autohemotherapy 
*Kaneko et al. [10]; ppt: total plasma protein **Imunocromatography for Ehrlichia canis; neg: negative; nr: not performed.
5O.M.M. Borges, C.L.M. Araújo, G.C. Ramalho, R.M.N. Silva, A. Tanikawa & A.P. Souza. 2017. Effects of Autohemotherapy 
on Hematologic Parameters and Morphology of Canine Oral Papillomatosis.          Acta Scientiae Veterinariae. 45(Suppl 1): 211.
to treat canine oral papillomatosis, being restricted to 
the initial measurement as an evaluation of the general 
state of the patient and/or diagnosis of possible basal 
diseases [4,6,7]. In this study, the blood counts remained 
unchanged during the entire therapy process, demon-
strating that the protocol adopted did not interfere in the 
dynamics of the red cells of this animal.
The increased platelets observed at M8 fol-
lowed by thrombocytopenia from M12 to M20 was 
correlated with the evolution of the macroscopic ap-
pearance of warts, with an increase in size and modi-
fication in color, texture, shape and consistency. This 
dynamics is possibly related to a platelet mobilization 
to the action site (warts), so that these modulate the 
immune response, aiding in the amplification of the 
inflammatory process and tissue repair [22], mediating 
the fall and involution of the papillomas.
This report shows the importance of perform-
ing more dosage studies involving intramuscular 
autohemotherapy in dogs with oral papillomatosis, 
emphasizing and correlating the relationship between 
the period of application intervals and the precocity of 
remission of the clinical symptoms.
CONCLUSION
Autohemotherapy applied at four-day intervals 
proved to be effective to treat a dog with moderate oral 
papillomatosis, with no clinical and laboratory side 
effects, and complete remission after 24 days of treat-
ment. The role of platelets in immune modulation and 
tissue repair should be further investigated, especially 
in the therapeutic involvement with AHT.
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